SIA
IRMD icon

Sit Investment Associates’s iRadimed IRMD Stock Holding History

Sit Investment Associates’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781K Buy
8,175
+4,725
+137% +$430K 0.01% 380
2026
Q1 		$332K Hold
3,450
– – 0.01% 419
2025
Q4 		$336K Hold
3,450
– – 0.01% 429
2025
Q3 		$246K Hold
3,450
– – 0.01% 438
2025
Q2 		$206K Hold
3,450
– – ﹤0.01% 451
2025
Q1 		$181K Buy
+3,450
New +$194K ﹤0.01% 454

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sit Investment Associates's IRMD Position: Q2 2026 in Review

Sit Investment Associates increased its iRadimed (IRMD) stake by 137% in Q2 2026, buying an estimated $430K and bringing the position to 8,175 shares worth $781K. The position accounts for 0.01% of the portfolio, ranked #380.

Sit Investment Associates first reported a position in IRMD in Q1 2025 and has held it in 6 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Sit Investment Associates held 8,175 shares of iRadimed worth $781K as of Q2 2026.
  • Sit Investment Associates bought 4,725 iRadimed shares in Q2 2026, an estimated $430K.
  • iRadimed made up 0.01% of Sit Investment Associates's portfolio in Q2 2026, its #380 holding.
  • Sit Investment Associates first reported a position in iRadimed in Q1 2025 and has held it in 6 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.